Halozyme Therapeutics HALO Proceeds from issuance of common stock under equity incentive plans, net of taxes paid related to net share settlement
Discontinued — last reported Q4 '25
Proceeds from issuance of common stock under equity incentive plans, net of taxes paid related to net share settlement at other companies
Other financials
Where this comes from
Reported directly by Halozyme Therapeutics in its filing.
Tagged under the XBRL concept halo:ProceedsFromPaymentsForIssuanceOfSharesShareBasedPaymentArrangementIncludingOptionExercised.
The official record: Halozyme Therapeutics’s 10-K, filed February 17, 2026, on SEC EDGAR. View the filing →
Ask your AI about Halozyme Therapeutics's proceeds from issuance of common stock under equity incentive plans, net of taxes paid related to net share settlement.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Halozyme Therapeutics's proceeds from issuance of common stock under equity incentive plans, net of taxes paid related to net share settlement?
- Halozyme Therapeutics (HALO) reported proceeds from issuance of common stock under equity incentive plans, net of taxes paid related to net share settlement of $4.15M in Q4 2025.
- How has Halozyme Therapeutics's proceeds from issuance of common stock under equity incentive plans, net of taxes paid related to net share settlement changed year-over-year?
- Halozyme Therapeutics's proceeds from issuance of common stock under equity incentive plans, net of taxes paid related to net share settlement increased by 15.6% year-over-year, from $3.59M to $4.15M.
- What is the long-term trend for Halozyme Therapeutics's proceeds from issuance of common stock under equity incentive plans, net of taxes paid related to net share settlement?
- Over 2 years (2021 to 2023), Halozyme Therapeutics's proceeds from issuance of common stock under equity incentive plans, net of taxes paid related to net share settlement has grown at a -20.7% compound annual growth rate (CAGR), from $12.54M to $7.88M.
- What does proceeds from issuance of common stock under equity incentive plans, net of taxes paid related to net share settlement mean?
- Cash received from employees exercising stock options or purchasing shares.
- How do you interpret proceeds from issuance of common stock under equity incentive plans, net of taxes paid related to net share settlement?
- Higher proceeds indicate higher employee participation in equity plans, though it also implies future dilution for existing shareholders.
- How does proceeds from issuance of common stock under equity incentive plans, net of taxes paid related to net share settlement compare across companies?
- Standard for companies with robust equity-based compensation structures.